The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
High frequency of gastrointestinal manifestations in myotonic dystrophy type 1 and type 2
Open accessAbstract
OBJECTIVE: To analyze gastrointestinal (GI) manifestations, their progression over time, and medications being used to treat GI symptoms in a large cohort of patients with myotonic dystrophy types 1 (DM1) and 2 (DM2). METHODS: We analyzed patient-reported data and medical records in a national registry cohort at baseline and 5 years. RESULTS: At baseline, the majority of patients reported trouble swallowing in DM1 (55%; n = 499 of 913) and constipation in DM2 (53%; n = 96 of 180). Cholecystectomy occurred in 16.5% of patients with DM1 and 12.8% of patients with DM2, on average before 45 years of age. The use of medications indicated for gastroesophageal reflux disease was reported by 22.5% of DM1 and 18.9% of patients with DM2. Greater risk of a GI manifestation was associated with higher body mass index and longer disease duration in DM1 and female sex in DM2. At the 5-year follow-up, the most common new manifestations were trouble swallowing in patients with DM1 and constipation in patients with DM2. CONCLUSIONS: GI manifestations were common in both DM1 and DM2, with a relatively high frequency of gallbladder removal in DM1 and DM2 occurring at a younger age compared to normative data in the literature. Studies are needed to determine the pathomechanism of how sex, weight gain, and duration of disease contribute to GI manifestations and how these manifestations affect quality of life and clinical care for patients with DM1 and DM2.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Gastrointestinal manifestations are common in myotonic dystrophy types 1 and 2, with high reported frequencies of constipation, diarrhea, abdominal pain, and dysphagia (Hilbert et al., 2017).”
From Autonomic nervous system and gastrointestinal manifestations with an emphasis on gastric dysfunction (2026) · cites this paper as Hilbert et al., 2017
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Brook, J. D., McCurrach, M. E., Harley, H. G., Buckler, A., Church, D. M., Aburatani, H., Hunter, K. W., Stanton, V. P., Thirion, J., Hudson, T. J., et al. (1992) · Cell · doi:10.1016/0092-8674(92)90154-5 · Cited by 2,754
Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review
El‐Serag, H. B., Sweet, S., Winchester, C., & Dent, J. (2013) · Gut · doi:10.1136/gutjnl-2012-304269 · Cited by 1,934
Myotonic Dystrophy Mutation: an Unstable CTG Repeat in the 3′ Untranslated region of the Gene
Mahadevan, M. S., Tsilfidis, C., Sabourin, L. A., Shutler, G., Amemiya, C. T., Jansen, G., Neville, C., Narang, M. A., Barceló, J. M., O'Hoy, K., et al. (1992) · Science · doi:10.1126/science.1546325 · Cited by 1,656
An Unstable Triplet Repeat in a Gene Related to Myotonic Muscular Dystrophy
Fu, Y., Pizzuti, A., Fenwick, R. G., King, J., Rajnarayan, S., Dunne, P. W., Dubel, J., Nasser, G. A., Ashizawa, T., de Jong, P., et al. (1992) · Science · doi:10.1126/science.1546326 · Cited by 1,453
Self-citationMyotonic Dystrophy Type 2 Caused by a CCTG Expansion in Intron 1 of ZNF9
Liquori, C. L., Ricker, K., Moseley, M. L., Jacobsen, J. F., Kreß, W., Naylor, S. L., Day, J., & Ranum, L. P. W. (2001) · Science · doi:10.1126/science.1062125 · Cited by 1,254
Self-citationThe Burden of Gastrointestinal and Liver Diseases, 2006
Shaheen, N. J., Hansen, R. A., Morgan, D. R., Gangarosa, L. M., Ringel, Y., Thiny, M. T., Russo, M. W., & Sandler, R. S. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00723.x · Cited by 694
Mitochondria: A central target for sex differences in pathologies
Ventura-Clapier, R., Moulin, M., Piquereau, J., Lemaire, C., Mericskay, M., Veksler, V., & Garnier, A. (2017) · Clinical Science · doi:10.1042/cs20160485 · Cited by 371
Genetic mapping of a second myotonic dystrophy locus
Ranum, L. P. W., Rasmussen, P. F., Benzow, K. A., Koob, M. D., & Day, J. (1998) · Nature Genetics · doi:10.1038/570 · Cited by 263
Self-citationCurrent Trends in the Management of Gastroesophageal Reflux Disease
Sandhu, D. S., & Fass, R. (2017) · Gut and Liver · doi:10.5009/gnl16615 · Cited by 218
Adverse Effects Associated With Proton Pump Inhibitors
Schoenfeld, A. J., & Grady, D. G. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.7927 · Cited by 214
Cited by
Sorted by citations
Gastrointestinal motility disorders in neurologic disease
Camilleri, M. (2021) · Journal of Clinical Investigation · doi:10.1172/jci143771 · Cited by 211
van den Bersselaar, L. R., Heytens, L., da Silva, H. C. A., Reimann, J., Tasca, G. A., Díaz‐Cambronero, Ó., Løkken, N., Hellblom, A., Hopkins, P. M., Rueffert, H., et al. (2022) · European Journal of Neurology · doi:10.1111/ene.15526 · Cited by 70
Consensus-based care recommendations for adults with myotonic dystrophy type 2
Schoser, B. G. H., Montagnese, F., Bassez, G., Fossati, B., Gámez, J., Heatwole, C. R., Hilbert, J. E., Kornblum, C., Kostera‐Pruszczyk, A., Krahe, R., et al. (2019) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000000645 · Cited by 67
Self-citationAssessing the influence of age and gender on the phenotype of myotonic dystrophy type 2
Montagnese, F., Mondello, S., Wenninger, S., Kreß, W., & Schoser, B. G. H. (2017) · Journal of Neurology · doi:10.1007/s00415-017-8653-2 · Cited by 57
Myotonic Dystrophies: Targeting Therapies for Multisystem Disease
LoRusso, S. J., Weiner, B., & Arnold, W. D. (2018) · Neurotherapeutics · doi:10.1007/s13311-018-00679-z · Cited by 50
Hamel, J. (2022) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000001184 · Cited by 42
Cardiac Pathology in Myotonic Dystrophy Type 1
Mahadevan, M. S., Yadava, R. S., & Mandal, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111874 · Cited by 34
Perna, A., Maccora, D., Rossi, S., Nicoletti, T. F., Zocco, M. A., Riso, V., Modoni, A., Petrucci, A., Valenza, V., Grieco, A., et al. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00394 · Cited by 31
Myotonic dystrophy type 2: the 2020 update.
Meola, G. (2020) · PubMed Central · doi:10.36185/2532-1900-026 · Cited by 31
Clinical and genetic characteristics of childhood‐onset myotonic dystrophy
Stokes, M. A., Varughese, N. A., Iannaccone, S. T., & Castro, D. (2019) · Muscle & Nerve · doi:10.1002/mus.26716 · Cited by 32
Gutiérrez‐Gutiérrez, G., Díaz‐Manera, J., Almendrote, M., Azriel, S., Bárcena, J. E., Cabezudo‐García, P., Salas, A. C., Rodríguez, C. C., Cobo, A. M., Guardiola, P. D., et al. (2019) · Neurología · doi:10.1016/j.nrl.2019.01.001 · Cited by 30
Gutiérrez‐Gutiérrez, G., Díaz‐Manera, J., Almendrote, M., Azriel, S., Bárcena, J. E., Cabezudo‐García, P., Salas, A. C., Rodríguez, C. C., Cobo, A.-M., Guardiola, P. D., et al. (2020) · Neurología (English Edition) · doi:10.1016/j.nrleng.2019.01.008 · Cited by 26
Clinical and Molecular Insights into Gastrointestinal Dysfunction in Myotonic Dystrophy Types 1 & 2
Peterson, J. A. M., & Cooper, T. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314779 · Cited by 24
Serres‐Bérard, T. D., Pierre, M., Chahine, M., & Puymirat, J. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105532 · Cited by 21
Fisette-Paulhus, I., Gagnon, C., Girard‐Côté, L., & Morin, M. (2022) · Neuromuscular Disorders · doi:10.1016/j.nmd.2022.01.008 · Cited by 21
An Antibody–Oligonucleotide Conjugate for Myotonic Dystrophy Type 1
Johnson, N. E., Tai, L.-J., Hamel, J., Day, J., Statland, J. M., Soltanzadeh, P., Subramony, S. H., Thornton, C. A., Arnold, W. D., Wicklund, M., et al. (2026) · New England Journal of Medicine · doi:10.1056/nejmoa2407326 · Cited by 20
Self-citationCellular Senescence and Aging in Myotonic Dystrophy
Hasuike, Y., Mochizuki, H., & Nakamori, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042339 · Cited by 22
Gutiérrez‐Gutiérrez, G., Díaz‐Manera, J., Almendrote, M., Azriel, S., Bárcena, J. E., Cabezudo‐García, P., Salas, A. C., Rodríguez, C. C., Cobo, A. M., Guardiola, P. D., et al. (2019) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2018.10.021 · Cited by 17
The prevalence of faecal incontinence in myotonic dystrophy type 1
Petty, R., Eugenicos, M. P., Hamilton, M., Farrugia, M. E., Robb, Y., Ballantyne, R., Gregory, H., McWilliam, C. A., & Longman, C. (2019) · Neuromuscular Disorders · doi:10.1016/j.nmd.2019.05.009 · Cited by 15
Zebrafish mbnl mutants model physical and molecular phenotypes of myotonic dystrophy
Hinman, M. N., Richardson, J. I., Sockol, R. A., Aronson, E. D., Stednitz, S. J., Murray, K. N., Berglund, J. A., & Guillemin, K. J. (2021) · Disease Models & Mechanisms · doi:10.1242/dmm.045773 · Cited by 15
Montagnese, F., Stahl, K., Wenninger, S., & Schoser, B. G. H. (2019) · Journal of Neurology · doi:10.1007/s00415-019-09593-6 · Cited by 15
Disturbance of the human gut microbiota in patients with Myotonic Dystrophy type 1
Mahdavi, M., Prévost, K., Balthazar, P., Fisette-Paulhus, I., Duchesne, É., Dumont, N. A., Gagné‐Ouellet, V., Gagnon, C., Laforest‐Lapointe, I., & Massé, É. (2024) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2024.05.009 · Cited by 11
The Gut Microbiota Involvement in the Panorama of Muscular Dystrophy Pathogenesis
Russo, C., Surdo, S., Valle, M. S., & Malaguarnera, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011310 · Cited by 12
Multisystem Symptoms in Myotonic Dystrophy Type 1: A Management and Therapeutic Perspective
Kuntawala, D. H., Vitorino, R. M. P., Cruz, A. C., Martins, F., & Rebelo, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26115350 · Cited by 12
Gutiérrez‐Gutiérrez, G., Díaz‐Manera, J., Almendrote, M., Azriel, S., Bárcena, J. E., Cabezudo‐García, P., Camacho, A., Rodríguez, C. C., Cobo, A. M., Guardiola, P. D., et al. (2019) · Medicina Clínica · doi:10.1016/j.medcli.2018.10.028 · Cited by 10
Gender difference in clinical conditions among hospitalized adults with myotonic dystrophy
Ouyang, L., Wang, Y., Valdez, R. A., Johnson, N. E., Gutmann, L., Street, N., & Bolen, J. (2018) · Muscle & Nerve · doi:10.1002/mus.26402 · Cited by 8
International collaboration to improve knowledge on myotonic dystrophy type 2
Perić, S., Ivanović, V., Ashley, E.-J., Esparis, B., Campbell, C., Wenninger, S., Monckton, D. G., Marini‐Bettolo, C., Walker, H., Voháňka, S., et al. (2024) · Journal of Neuromuscular Diseases · doi:10.1177/22143602241290353 · Cited by 6
New developments in myotonic dystrophies from a multisystemic perspective
Montagnese, F., & Schoser, B. G. H. (2021) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000964 · Cited by 6
Kambayashi, T., Hirano‐Kawamoto, A., Takahashi, T., Taniguchi, S., Yoshioka, M., Tanaka, H., Oizumi, H., Totsune, T., Oshiro, S., Baba, T., et al. (2022) · Auris Nasus Larynx · doi:10.1016/j.anl.2022.04.003 · Cited by 6
Graves’ disease and celiac disease in a patient with myotonic dystrophy type 2
Damen, M. J., van der Meer, A., Voermans, N. C., & Tieleman, A. A. (2018) · Neuromuscular Disorders · doi:10.1016/j.nmd.2018.07.003 · Cited by 6
Oropharyngeal dysphagia in early stages of myotonic dystrophy type 1
Franco‐Guerrero, A. A., Márquez-Quiróz, L., Valadez-Jiménez, V. M., Cortés, H., Murillo-Melo, N. M., Muñoz, B., Cisneros, B., & Magaña, J. J. (2019) · Muscle & Nerve · doi:10.1002/mus.26485 · Cited by 6
Gender disparities in myotonic dystrophy 1
Chakraborty, D., Borthakur, S., Sarkar, R., & Singh, M. D. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123659 · Cited by 5
Myotonic dystrophy type 1 presenting with dyspnea: A case report
Jia, Y., Dong, C., Xue, J.-W., Duan, X., Xu, M.-Y., Su, X., & Li, P. (2022) · World Journal of Clinical Cases · doi:10.12998/wjcc.v10.i20.7060 · Cited by 5
González-Martínez, I., Cerro-Herreros, E., Carrascosa-Sàez, M., García-Rey, A., Piqueras‐Losilla, D., Colom-Rodrigo, A., Moreno, N., Chakraborty, M., Huguet-Lachon, A., González‐Barriga, A., et al. (2026) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2026.01.016 · Cited by 4
Anesthésie et maladies neuromusculaires : myopathies et myasthénie
Dépret, F., Deniau, B., & Plaud, B. (2023) · Anesthésie & Réanimation · doi:10.1016/j.anrea.2023.02.004 · Cited by 4
The Impact of Heritable Myopathies on Gastrointestinal Skeletal Muscle Function
Iyer, A. S., Alizadeh, M. A., Mariano, J. M., Kontrogianni‐Konstantopoulos, A., & Raufman, J. (2025) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2025.101522 · Cited by 4
Ghazaleh, S., Nehme, C., Khader, Y., Hasan, S., & Nawras, A. T. (2020) · Gastroenterology and hepatology from bed to bench. · Cited by 4
Marín, J. P. S., Bailo, P. S., Alonso, R. L., Liesa, J. L. C., Abío, J. G., Muñoz, J. Á., Pardo, P. J. M., Baron, B., & Álvarez, S. I. (2023) · Neurología (English Edition) · doi:10.1016/j.nrleng.2023.07.001 · Cited by 4
Scholten, S., Peterson, J. A. M., Orriëns, L. B., Pastorelli, L., Meola, G., Schoser, B. G. H., Braakman, H. M. H., Scholten, S., Peterson, J., Orriëns, L., et al. (2025) · Neuromuscular Disorders · doi:10.1016/j.nmd.2025.106250 · Cited by 3
Ancestral Origin of the First Indian Families with Myotonic Dystrophy Type 2
Damen, M. J., Schijvenaars, M. M. V. A. P., Naber, M., Groothuismink, J. M., Coenen, M. J. H., & Tieleman, A. A. (2021) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-210671 · Cited by 3
Peterson, J. A. M., Frias, J. A., Miller, A. N., Soni, K. G., Zhang, Y., Xia, Z., Day, J., Preidis, G. A., & Cooper, T. A. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2522788122 · Cited by 2
Self-citationCole, M. R., Cooper, C. S., Hanna, E. M., Zimmerman, M. B., Kinoshita, J., & Mathews, K. D. (2023) · Muscle & Nerve · doi:10.1002/mus.28028 · Cited by 2
Self-citationMarín, J. P. S., Bailo, P. S., Alonso, R. L., Liesa, J. L. C., Abío, J. G., Muñoz, J. Á., Pardo, P. J. M., Baron, B., & Álvarez, S. I. (2021) · Neurología · doi:10.1016/j.nrl.2021.02.012 · Cited by 2
van Hees, S., Knuijt, S., Dicke, H., Groothuis, J. T., Raaphorst, J., Satink, T., & Cup, E. H. C. (2018) · Disability and Rehabilitation · doi:10.1080/09638288.2018.1528305 · Cited by 2
Myotonic dystrophy type 1 complicated by colonic obstruction due to a bezoar
de Souza, A., & Gupta, S. (2019) · Annals of Indian Academy of Neurology · doi:10.4103/aian.aian_529_18 · Cited by 2
Acute Pancreatitis Associated With Myotonic Dystrophy Type I
Pezzilli, R., & Mauloni, P. A. (2019) · Pancreas · doi:10.1097/mpa.0000000000001366 · Cited by 2
Moxley, R. T., Hilbert, J. E., & Meola, G. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813866-3.00029-1 · Cited by 1
Self-citationSilvestri, G., & Modoni, A. (2023) · Current clinical neurology · doi:10.1007/978-3-031-44009-0_3 · Cited by 1
la Fontaine, L. A., Veen, B. V., Hamadeh, T., Conchillo, J. M., van Kuijk, S. M. J., Merkies, I. S. J., & Faber, C. G. (2026) · Journal of Neuromuscular Diseases · doi:10.1177/22143602251412672 · Cited by 1
Life Expectancy and Causes of Death in Patients with Myotonic Dystrophy Type 2
Damen, M. J., Muilwijk, O. G., Dubbelink, T. B. G. O., van Engelen, B. G. M., Voermans, N. C., & Tieleman, A. A. (2024) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-240089 · Cited by 1
Common Characteristics Between Frailty and Myotonic Dystrophy Type 1: A Narrative Review
Garmendia, J., Labayru, G., Barreto, P. D. S., Vergara, I., de Munaín, A. L., & Sistiaga, A. (2024) · Aging and Disease · doi:10.14336/ad.2024.0950 · Cited by 1
Moxley, R. T., Hilbert, J. E., & Meola, G. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19176-3.00029-7 · Cited by 1
Self-citationJoosten, I. B. T., Okkersen, K., van Engelen, B. G. M., & Faber, C. G. (2020) · doi:10.1002/9781119432692.ch39 · Cited by 1
Silvestri, G., Maccora, D., Perna, A., Rossi, S., & Valenza, V. (2018) · Neurology · doi:10.1212/wnl.0000000000005366 · Cited by 1
Autonomic nervous system and gastrointestinal manifestations with an emphasis on gastric dysfunction
Shouman, K., Camilleri, M., & Singer, W. (2026) · Autonomic Neuroscience · doi:10.1016/j.autneu.2026.103474
Hypersomnolence secondaire à une dystrophie myotonique de type 1 sans myotonie clinique
Lambert, I., & Sevy, A. (2018) · Médecine du Sommeil · doi:10.1016/j.msom.2018.03.001
Hilbert, J. E., Thornton, C. A., & Moxley, R. T. (2018) · Neurology · doi:10.1212/wnl.0000000000005370
Self-citationGastrointestinal Complications of Neuromuscular Disorders
Ismail, M. K., & Shrestha, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-71317-7.00004-4
Sporadic Myotonic Dystrophy Type 2 in a Japanese Patient
Miyashita, K., Ii, Y., Matsuyama, H., Niwa, A., Kawana, Y., Shibata, S., Minami, N., Nishino, I., & Tomimoto, H. (2023) · Internal Medicine · doi:10.2169/internalmedicine.0425-22
Joosten, I. B. T. (2023) · doi:10.26481/dis.20231023ij
Neuromuscular Disorders With Gastrointestinal Tract Affection
Finsterer, J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95702-1.00125-1
Gestion péri-opératoire du patient atteint d'une myopathie ou d'une myasthénie
Dépret, F., Deniau, B., & Plaud, B. (2024) · Elsevier eBooks · doi:10.1016/b978-2-294-78187-2.00021-2
Zhang, Y., Wallace, B., Cai, B., Johnson, N. E., Ciafaloni, E., Venkatesh, Y. S., Westfield, C. P., & McDermott, S. W. (2024) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-024-03359-8
Neuromuscular Diseases Characterized by Abnormal Muscle Activities
Kimura, J., & Strakowski, J. A. (2025) · Oxford University Press eBooks · doi:10.1093/med/9780197658017.003.0028
Al‐Beltagi, M., Saeed, N. K., Bediwy, A. S., & Elbeltagi, R. M. (2025) · World Journal of Methodology · doi:10.5662/wjm.v15.i4.102408
Gastrointestinal Manifestations As the Initial Presentation of Neurological Disease
Datla, P., Gopalan, S., & Arthur, P. (2025) · Cureus · doi:10.7759/cureus.93615
Multisystem Features in Adult-Onset Myotonic Dystrophy Type 1: An Integrative Case Analysis
Böckels, L., Alexa, D., Cretu, R. A., Vicol, M., Hodorogea, B., Gramada, D., Apostol, G., Achiroaie, D., Bîlcu, R. V., & Cuciureanu, D. I. (2025) · Balneo and PRM Research Journal · doi:10.12680/balneo.2025.928
Current biomarker development in myotonic dystrophies
Larsen, M., Mendelsohn, D. H., Kleefeld, F., Meinke, P., & Schoser, B. G. H. (2026) · Journal of Neurology · doi:10.1007/s00415-026-13888-w
Iterbeke, L., Ponsaerts, B., Demedts, I., Aelst, L. N. L. V., Buyse, B., & Claeys, K. G. (2026) · Neuromuscular Disorders · doi:10.1016/j.nmd.2026.107374
Metadata
- Authors
- Hilbert, J. E., Barohn, R. J., Clemens, P. R., Luebbe, E. A., Martens, W. B., McDermott, M. P., Parkhill, A. L., Tawil, R., Thornton, C. A., Moxley, R. T., National Registry Scientific Advisory Committee/Investigators, Ashizawa, T., Barohn, R. J., Clemens, P. R., Conneally, P. M., Day, J. W., Figlewicz, D. A., Jackson, J. M., Kissel, J. T., Lord, S., Mathews, K. D., Sanders, D. B., & Tapscott, S. J.
- Affiliations
- University of Pittsburgh (US)
- ORCID
- Venue
- Neurology
- Published
- 2017-09-26
- Volume
- 89
- Issue
- 13
- Pages
- 1348-1354
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- PMC
- PMC5649763
- OpenAlex
- W2753249033
- Cited by
- 70
- References
- 39
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 9 · 2023: 6 · 2022: 7 · 2021: 8 · 2020: 7 · 2019: 10 · 2018: 7 · 2017: 1
- FWCI
- 3.35
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Neurology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Fisher Digital Publications (St. John Fisher College) (submittedVersion)
- Funders
- National Institutes of Health (5u54ns048843-12)
- Medical Center, University of Rochester
- National Institute of Neurological Disorders and Stroke (U54‐NS048843)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Keywords
- myotonic dystrophy type 1, myotonic dystrophy type 2, gastrointestinal manifestations, dysphagia, constipation, cholecystectomy, gastroesophageal reflux disease, body mass index, disease duration, sex differences, disease progression
- MeSH terms
- Age Factors, Cholecystectomy, Female, Follow-Up Studies, Gastrointestinal Diseases, Humans, Male, Middle Aged, Myotonic Dystrophy, Registries, Risk Factors, Sex Factors, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
